CA 19-9-259

Test info

  
CA 19-9
  
259
  
86301.0
  
C19
  
Cancer antigen 19-9
Carbohydrate antigen 19-9
CA 19-9 Tumor marker
C19
  

The test method changed on 1/3/2023. If this test has been used for serial monitoring, rebaselining is recommended. Rebaselining consists of 2 measurements, collected 3-6 weeks apart.
The Roche Elecsys CEA assay is an electrochemiluminescence immunoassay "ECLIA" performed on the Roche Cobas "e" immunoassy analyzers.
Values obtained with different assay methods may be different and cannot be used interchangeably.

  

Biotin supplements may cause clinically significant interference for this test assay. If interference is suspected, it is strongly recomended that biotin is discontinued for at least one week prior to retesting.

Specimen

  
Serum
  
  
1.0 mL
  
0.5 mL
  

Immediately following collection, mix sample by gently inverting 5 times

  
  1. Allow sample to clot for a minimum of 30 minutes
  2. Spin within two (2) hours of sample collection
  

Gold serum separator (SST) tube

  
Serum
Lithium heparin (Li hep) plasma
  
  

Immediately following collection, mix sample thoroughly by gently inverting 8 - 10 times

  

Red:

  1. Allow sample to clot
  2. Spin
  3. Transfer serum to a False bottom plasma/serum transport vial/tube (AHL), labelled as serum, within two (2) hours of sample collection

 

Lt green:

  1. Spin within two (2) hours of sample collection
  

Lt green plasma separator (PST)

False bottom plasma/serum transport vial/tube (AHL)

  

Refrigerated - 14 days

Ambient - 5 days

Frozen - 3 months

  
  • Improper labels (unlabeled or mislabeled)
  • Hemolysis (some procedures)
  • Improper anticoagulant or ratio
  • Delay in transport
  • Improper storage temperature affecting results
  • Improper container
  • Leaking container resulting in compromised specimen
  • Quantity not sufficient (QNS)

Performance

  
AHL - Chemistry: C
  
Mo - Sa
  
2 days
  

Electrochemiluminescence immunoassay (ECLIA)

Clinical and Interpretive info

  

≤ 35 IU/mL

  

Should not be used as a screening test

Billing

  
86301
  
Yes
  

Tracking

  
11/30/2001
  
12/23/2022
  
11/09/2021